Viewing Study NCT03436693


Ignite Creation Date: 2025-12-25 @ 1:10 AM
Ignite Modification Date: 2026-04-13 @ 5:58 AM
Study NCT ID: NCT03436693
Status: COMPLETED
Last Update Posted: 2024-07-15
First Post: 2018-02-01
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy
Sponsor: Tanabe Pharma Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetic Nephropathy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diabetic Nephropathy View
None Canagliflozin View
None Canaglu View
None Diabetes Mellitus, Type 2 View